Principal Investigator
Research Scientist in Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health; Member, Center for Infection and Immunity
Our team
Business Development
Communications & Engagement
Laboratory and Research
Yale Regulatory Support
Yale Office of Public Health Practice
Advisory board
Yale School of Medicine, Yale School of Management, Health Policy and Management
Professor of Radiology and Biomedical Imaging, in the Institute for Social and Policy Studies, of Economics, of Management and of Public Health (Health Policy); Director of MD/MBA Program at Yale; Director, MBA for Executives (Healthcare Focus Area); SOM; Director, Health Care Management Program; YSPH; Faculty Director of Finance; Department of Radiology; YSM
Yale School of Public Health
Associate Professor of Epidemiology (Microbial Diseases); Affiliated Faculty, Yale Institute for Global Health
Past team members
- Sumaira Akbarzada
- Kashif Ahmed
- Taiwo Ajibola
- Kimberly Bako
- Eli Bierman
- Megan Briggs
- Victor Elisha
- Lily Kitfield-Vernon
- Hunter Larson
- Sarah Megiel
- Yashna Nainani
- Samson Osuntokun Oluwale
- Leah Salzano
- Catherine Santiago
- Wells Tu
- Alison Zerbib
Important Regulatory Information about SalivaDirect™
SalivaDirect™has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization for use by authorized laboratories. The test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.